Uncertainties lingers in pharmaceutical industry

In recent years, uncertainty has tended to increase in Korea’s pharmaceutical industry as a result of the government’s campaign to lower drug prices and due to the rampant use of illegal rebates.

To lower drug prices, the government has implemented a series of measures, including the “positive list system,” which offers health insurance benefits only to low-price, high-efficacy drugs; the “p...